In Brief | Published:

CLINICAL TRIALS

Safety concerns of rivaroxaban use in APS

Nature Reviews Rheumatology (2018) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

    Original article

    1. Pengo, V. et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. Blood https://doi.org/10.1182/blood-2018-04-848333 (2018)

    Download references

    Author information

    Affiliations

    1. Nature Reviews Rheumatology

      • Jessica McHugh

    Authors

    1. Search for Jessica McHugh in:

    Corresponding author

    Correspondence to Jessica McHugh.

    About this article

    Publication history

    Published

    DOI

    https://doi.org/10.1038/s41584-018-0067-8

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing